Clover Health Investments (NASDAQ:CLOV) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. This is a 350 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $743.167 million which beat the analyst consensus estimate of $728.267 million by 2.05 percent. This is a 55.60 percent increase over sales of $477.620 million the same period last year.